Sign Up to like & get
recommendations!
0
Published in 2019 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.601
Abstract: The objective of this study was to evaluate the relative bioavailability of olanzapine in 3 olanzapine‐containing tablet formulations. ALKS 3831 is a fixed‐dose combination of olanzapine (OLZ, an atypical antipsychotic) and samidorphan (SAM, a μ‐opioid…
read more here.
Keywords:
bioequivalence;
alks 3831;
olz;
olanzapine ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "AAPS PharmSciTech"
DOI: 10.1208/s12249-018-1213-y
Abstract: Potential risk of agranulocytosis is one of the drug-induced adverse effects of the second-generation antipsychotic agents. The present investigation aimed to formulate and investigate olanzapine (OLZ)-loaded nanostructured lipid carriers (OLZ-NLCs) via intranasal (i.n.) route. The…
read more here.
Keywords:
loaded nanostructured;
olz mnlc;
delivery;
olz ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14081535
Abstract: The work evaluates the stability of amorphous and co-amorphous olanzapine (OLZ) in tablets manufactured by direct compression. The flowability and the compressibility of amorphous and co-amorphous OLZ with saccharin (SAC) and the properties of the…
read more here.
Keywords:
amorphous olanzapine;
crystalline olz;
amorphous amorphous;
amorphous olz ... See more keywords